Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Jul. 29, 2018	Jul. 30, 2017	Jul. 31, 2016
Cash flows from operating activities:
Net earnings	$ 261	$ 887	$ 563
Adjustments to reconcile net earnings to operating cash flow
Asset Impairment Charges	748	212	141
Restructuring charges	62	18	31
Stock-based compensation	61	60	64
Amortization of inventory fair value adjustment from acquisition	42	0	0
Pension and postretirement benefit expense (income)	(187)	(258)	317
Depreciation and amortization	394	318	308
Deferred income taxes	(133)	93	(30)
Other, net	34	18	6
Changes in working capital, net of acquisitions
Accounts receivable	56	28	24
Inventories	(84)	46	59
Prepaid assets	27	(27)	9
Accounts payable and accrued liabilities	78	(48)	15
Net receipts from hedging activities	6	2	44
Other	(60)	(58)	(60)
Net cash provided by operating activities	1,305	1,291	1,491
Cash flows from investing activities:
Purchases of plant assets	(407)	(338)	(341)
Sales of plant assets	1	0	5
Purchases of route businesses	(9)	0	0
Sales of route businesses	10	0	0
Business acquired, net of cash acquired	(6,772)	0	0
Other, net	(20)	(30)	(18)
Net cash used in investing activities	(7,197)	(368)	(354)
Cash flows from financing activities:
Short-term borrowings	10,222	8,247	8,161
Short-term repayments	(9,944)	(8,002)	(8,923)
Long-term borrowings	6,224	211	215
Long-term repayments	(63)	(90)	0
Repayments of notes payable	0	(400)	0
Dividends paid	(426)	(420)	(390)
Treasury stock purchases	(86)	(437)	(143)
Treasury stock issuances	0	2	2
Payments related to tax withholding for stock-based compensation	(23)	(22)	(21)
Repurchase of noncontrolling interest	(47)	0	0
Payments of debt issuance costs	(50)	0	0
Net cash provided by (used in) financing activities	5,807	(911)	(1,099)
Effect of exchange rate changes on cash	(8)	11	5
Net change in cash and cash equivalents	(93)	23	43
Cash and cash equivalents - beginning of period	319	296	253
Cash and cash equivalents - end of period	$ 226	$ 319	$ 296